Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Clinical Medicine|March 28, 2026
Artificial Intelligence in Asthma and COPD: Current Status and Future PotentialFederica Marrelli, Chiara Lupia, Saverio Nucera, et al.Expert Opinion on Emerging Drugs|January 28, 2025
Emerging biological treatments for asthmaDaniela Pastore, Chiara Lupia, Maria D'Amato, et al.Pragmatic and Observational Research|March 18, 2024
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.Case Reports in Pulmonology|March 6, 2026
Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP)Chiara Lupia, Giovanna Lucia Piazzetta, Daniela Pastore, et al.Advances in Respiratory Medicine|October 28, 2025
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled AsthmaAntonio Maiorano, Anna Ferrante Bannera, Chiara Lupia, et al.Journal of Clinical Medicine|July 12, 2025
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted ApproachMaria D'Amato, Daniela Pastore, Chiara Lupia, et al.Pulmonary Therapy|June 3, 2026
Impact of Single-Inhaler Triple Therapy FF/UMEC/VI on Disease Stability in COPD: A Real-World 12-Month AnalysisChiara Lupia, Daniela Pastore, Antonio Giacalone, et al.Journal of Clinical Medicine|May 27, 2026
Severe Eosinophilic Asthma: From Immunopathology to Pharmacological TreatmentDaniela Pastore, Chiara Lupia, Emanuela Chiarella, et al.Journal of Clinical Medicine|January 28, 2026
Short-Term Effects of Dupilumab in Eosinophilic COPDChiara Lupia, Daniela Pastore, Giuseppina Marrazzo, et al.Frontiers in Pharmacology|February 16, 2026
Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remissionChiara Lupia, Caterina Battaglia, Daniela Pastore, et al.Pageof 2